Promis Neurosciences Stock Performance

PMN Stock  USD 13.10  2.55  16.29%   
On a scale of 0 to 100, ProMIS Neurosciences holds a performance score of 8. The company holds a Beta of -0.34, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ProMIS Neurosciences are expected to decrease at a much lower rate. During the bear market, ProMIS Neurosciences is likely to outperform the market. Please check ProMIS Neurosciences' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether ProMIS Neurosciences' historical price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ProMIS Neurosciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, ProMIS Neurosciences displayed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(2.82)
Five Day Return
(31.93)
Year To Date Return
78.29
Ten Year Return
(83.03)
All Time Return
(99.29)
Last Split Factor
1:25
Last Split Date
2025-11-28
1
12 Health Care Stocks Moving In Wednesdays Pre-Market Session
11/19/2025
2
ProMIS Neurosciences Announces Reverse Stock Split
11/24/2025
3
Insider Trading
12/03/2025
4
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimers Disease
12/18/2025
5
Disposition of 697674 shares by Sclar Jeremy M. of ProMIS Neurosciences subject to Rule 16b-3
12/24/2025
6
Market Moves Can ProMIS Neurosciences Inc continue delivering strong returns - Market Growth Summary Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
01/14/2026
7
Disposition of 697674 shares by Jeremy M. Sclar 2012 Irrevocable Family Trust of ProMIS Neurosciences subject to Rule 16b-3
01/28/2026
8
Acquisition by Abg Management Ltd. of 700741 shares of ProMIS Neurosciences at 14.4 subject to Rule 16b-3
02/03/2026
Begin Period Cash Flow12.6 M
Total Cashflows From Investing Activities-693.00

ProMIS Neurosciences Relative Risk vs. Return Landscape

If you would invest  975.00  in ProMIS Neurosciences on November 9, 2025 and sell it today you would earn a total of  335.00  from holding ProMIS Neurosciences or generate 34.36% return on investment over 90 days. ProMIS Neurosciences is generating 0.75% of daily returns assuming volatility of 7.3436% on return distribution over 90 days investment horizon. In other words, 65% of stocks are less volatile than ProMIS, and above 85% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon ProMIS Neurosciences is expected to generate 8.96 times more return on investment than the market. However, the company is 8.96 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

ProMIS Neurosciences Target Price Odds to finish over Current Price

The tendency of ProMIS Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 13.10 90 days 13.10 
roughly 2.33
Based on a normal probability distribution, the odds of ProMIS Neurosciences to move above the current price in 90 days from now is roughly 2.33 (This ProMIS Neurosciences probability density function shows the probability of ProMIS Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon ProMIS Neurosciences has a beta of -0.34 indicating as returns on the benchmark increase, returns on holding ProMIS Neurosciences are expected to decrease at a much lower rate. During a bear market, however, ProMIS Neurosciences is likely to outperform the market. Additionally ProMIS Neurosciences has an alpha of 0.6015, implying that it can generate a 0.6 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   ProMIS Neurosciences Price Density   
       Price  

Predictive Modules for ProMIS Neurosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ProMIS Neurosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
5.2412.6019.96
Details
Intrinsic
Valuation
LowRealHigh
11.7923.5230.88
Details
Naive
Forecast
LowNextHigh
8.4415.8023.16
Details
3 Analysts
Consensus
LowTargetHigh
52.5257.7164.06
Details

ProMIS Neurosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ProMIS Neurosciences is not an exception. The market had few large corrections towards the ProMIS Neurosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ProMIS Neurosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ProMIS Neurosciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.60
β
Beta against Dow Jones-0.34
σ
Overall volatility
1.97
Ir
Information ratio 0.07

ProMIS Neurosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ProMIS Neurosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ProMIS Neurosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ProMIS Neurosciences is way too risky over 90 days horizon
ProMIS Neurosciences appears to be risky and price may revert if volatility continues
ProMIS Neurosciences has high likelihood to experience some financial distress in the next 2 years
ProMIS Neurosciences has about 8.95 M in cash with (27.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
ProMIS Neurosciences has a frail financial position based on the latest SEC disclosures
Roughly 25.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Acquisition by Abg Management Ltd. of 700741 shares of ProMIS Neurosciences at 14.4 subject to Rule 16b-3

ProMIS Neurosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ProMIS Stock often depends not only on the future outlook of the current and potential ProMIS Neurosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ProMIS Neurosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.1 M
Cash And Short Term Investments13.3 M

ProMIS Neurosciences Fundamentals Growth

ProMIS Stock prices reflect investors' perceptions of the future prospects and financial health of ProMIS Neurosciences, and ProMIS Neurosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ProMIS Stock performance.

About ProMIS Neurosciences Performance

By examining ProMIS Neurosciences' fundamental ratios, stakeholders can obtain critical insights into ProMIS Neurosciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that ProMIS Neurosciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.13  0.14 
Return On Capital Employed(0.91)(0.95)
Return On Assets 0.13  0.14 
Return On Equity 0.15  0.16 

Things to note about ProMIS Neurosciences performance evaluation

Checking the ongoing alerts about ProMIS Neurosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ProMIS Neurosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ProMIS Neurosciences is way too risky over 90 days horizon
ProMIS Neurosciences appears to be risky and price may revert if volatility continues
ProMIS Neurosciences has high likelihood to experience some financial distress in the next 2 years
ProMIS Neurosciences has about 8.95 M in cash with (27.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
ProMIS Neurosciences has a frail financial position based on the latest SEC disclosures
Roughly 25.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Acquisition by Abg Management Ltd. of 700741 shares of ProMIS Neurosciences at 14.4 subject to Rule 16b-3
Evaluating ProMIS Neurosciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ProMIS Neurosciences' stock performance include:
  • Analyzing ProMIS Neurosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ProMIS Neurosciences' stock is overvalued or undervalued compared to its peers.
  • Examining ProMIS Neurosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ProMIS Neurosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ProMIS Neurosciences' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of ProMIS Neurosciences' stock. These opinions can provide insight into ProMIS Neurosciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ProMIS Neurosciences' stock performance is not an exact science, and many factors can impact ProMIS Neurosciences' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether ProMIS Neurosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProMIS Neurosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Promis Neurosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Promis Neurosciences Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Biotechnology sector continue expanding? Could ProMIS diversify its offerings? Factors like these will boost the valuation of ProMIS Neurosciences. Anticipated expansion of ProMIS directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ProMIS Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(20.00)
Revenue Per Share
0.001
Return On Assets
(0.85)
Return On Equity
(3.56)
ProMIS Neurosciences's market price often diverges from its book value, the accounting figure shown on ProMIS's balance sheet. Smart investors calculate ProMIS Neurosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since ProMIS Neurosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between ProMIS Neurosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProMIS Neurosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.